11月4日 - Surmodics Inc公告:*SURMODICS公布在PROWL登记中评估POUNCE™血栓切除平台治疗真实世界肢体缺血的160名患者的结果*SURMODICS INC - 手术成功率91.7%,设备相关不良事件0.6%*SURMODICS INC - 94.8%的患者在手术后经历了血流恢复*SURMODICS INC - 设备技术成功率为83.2%,残余阻塞率低于50%
11月4日 - Surmodics Inc公告:*SURMODICS公布在PROWL登记中评估POUNCE™血栓切除平台治疗真实世界肢体缺血的160名患者的结果*SURMODICS INC - 手术成功率91.7%,设备相关不良事件0.6%*SURMODICS INC - 94.8%的患者在手术后经历了血流恢复*SURMODICS INC - 设备技术成功率为83.2%,残余阻塞率低于50%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.